Cargando…
Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review
RATIONALE: Regular consumption of gamma-hydroxybutyrate (GHB) may result in a dependence syndrome that can lead to withdrawal symptoms. There are limited data on medications to manage GHB withdrawal. OBJECTIVES: To examine characteristics associated with delirium and discharge against medical advice...
Autores principales: | Siefried, Krista J., Freeman, Georgia, Roberts, Darren M., Lindsey, Rhiannon, Rodgers, Craig, Ezard, Nadine, Brett, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816228/ https://www.ncbi.nlm.nih.gov/pubmed/36508055 http://dx.doi.org/10.1007/s00213-022-06283-6 |
Ejemplares similares
-
Understandings, attitudes, practices and responses to GHB overdose among GHB consumers
por: Freestone, Jack, et al.
Publicado: (2023) -
“There’s a big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia
por: Clifford, Brendan, et al.
Publicado: (2023) -
Characterization of the GHB Withdrawal Syndrome
por: Wolf, Casper J. H., et al.
Publicado: (2021) -
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal
por: Acheson, Liam S., et al.
Publicado: (2022) -
A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia
por: Siefried, Krista J., et al.
Publicado: (2021)